The results demonstrated that serum AIFM3 level was associated with lymph node metastasis, age, and survival time (p = 0.001, p = 0.002, and p = 0.017, respectively), but not with other parameters (Table 2). Here, AIFM3 is linked to metastatic malignant neoplasm in the lymph nodes.